DK171487B1 - Kationiske komplekser med technetium-99m, komplekserne til anvendelse som hjerteafbildende midler og ligander, der er anvendelige i sådanne komplekser - Google Patents
Kationiske komplekser med technetium-99m, komplekserne til anvendelse som hjerteafbildende midler og ligander, der er anvendelige i sådanne komplekser Download PDFInfo
- Publication number
- DK171487B1 DK171487B1 DK266689A DK266689A DK171487B1 DK 171487 B1 DK171487 B1 DK 171487B1 DK 266689 A DK266689 A DK 266689A DK 266689 A DK266689 A DK 266689A DK 171487 B1 DK171487 B1 DK 171487B1
- Authority
- DK
- Denmark
- Prior art keywords
- heart
- ligand
- ether
- formula
- liver
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 62
- 125000002091 cationic group Chemical group 0.000 title claims abstract description 22
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 title claims abstract description 10
- 239000012216 imaging agent Substances 0.000 title claims abstract description 9
- 229940056501 technetium 99m Drugs 0.000 title claims abstract description 6
- 230000000747 cardiac effect Effects 0.000 title claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 125
- 101100407084 Caenorhabditis elegans parp-2 gene Proteins 0.000 claims description 26
- GKKWUSPPIQURFM-IGDGGSTLSA-N Prostaglandin E2 ethanolamide Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)NCCO GKKWUSPPIQURFM-IGDGGSTLSA-N 0.000 claims description 26
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 23
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 13
- 125000001033 ether group Chemical group 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 150000001450 anions Chemical class 0.000 claims description 6
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 8
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 7
- 239000011574 phosphorus Substances 0.000 abstract description 6
- 229910052785 arsenic Chemical group 0.000 abstract description 3
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical group [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 abstract description 3
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 83
- 239000000243 solution Substances 0.000 description 57
- 210000004369 blood Anatomy 0.000 description 55
- 239000008280 blood Substances 0.000 description 55
- 210000003205 muscle Anatomy 0.000 description 55
- 210000004072 lung Anatomy 0.000 description 51
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 45
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 32
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 29
- 239000011780 sodium chloride Substances 0.000 description 29
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 210000000056 organ Anatomy 0.000 description 27
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 21
- 241000700159 Rattus Species 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 239000000463 material Substances 0.000 description 20
- 210000002700 urine Anatomy 0.000 description 20
- 238000004128 high performance liquid chromatography Methods 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- 238000004587 chromatography analysis Methods 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 210000004556 brain Anatomy 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000001727 in vivo Methods 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000084 colloidal system Substances 0.000 description 13
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 13
- 239000011734 sodium Substances 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 238000001502 gel electrophoresis Methods 0.000 description 11
- 229910052713 technetium Inorganic materials 0.000 description 11
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 11
- 241000700198 Cavia Species 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- -1 cationic technetium-99m complexes Chemical class 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 241000349731 Afzelia bipindensis Species 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- IHLVCKWPAMTVTG-UHFFFAOYSA-N lithium;carbanide Chemical compound [Li+].[CH3-] IHLVCKWPAMTVTG-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 6
- 101150041968 CDC13 gene Proteins 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000006286 aqueous extract Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 150000003003 phosphines Chemical class 0.000 description 5
- 235000014786 phosphorus Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000011208 chromatographic data Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 125000004437 phosphorous atom Chemical group 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- VFGXTUUYFAIEIJ-UHFFFAOYSA-N (3-dimethylphosphanyl-1,3-dimethoxypropyl)-dimethylphosphane Chemical compound COC(P(C)C)CC(OC)P(C)C VFGXTUUYFAIEIJ-UHFFFAOYSA-N 0.000 description 3
- YTTFFPATQICAQN-UHFFFAOYSA-N 2-methoxypropan-1-ol Chemical compound COC(C)CO YTTFFPATQICAQN-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000002026 chloroform extract Substances 0.000 description 3
- YOTZYFSGUCFUKA-UHFFFAOYSA-N dimethylphosphine Chemical compound CPC YOTZYFSGUCFUKA-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000012217 radiopharmaceutical Substances 0.000 description 3
- 229940121896 radiopharmaceutical Drugs 0.000 description 3
- 230000002799 radiopharmaceutical effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- AFJQIFVWBAWDHM-UHFFFAOYSA-N 1,3-dichloro-1,3-dimethoxypropane Chemical compound COC(Cl)CC(Cl)OC AFJQIFVWBAWDHM-UHFFFAOYSA-N 0.000 description 2
- VOVJNZRMKVAIRB-UHFFFAOYSA-N 1-dimethylphosphoryl-2-(dimethylphosphorylmethyl)-3-methoxy-2-(methoxymethyl)propane Chemical compound COCC(COC)(CP(C)(C)=O)CP(C)(C)=O VOVJNZRMKVAIRB-UHFFFAOYSA-N 0.000 description 2
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 2
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 description 2
- UCMPIDSRISWZLR-UHFFFAOYSA-N 4,4-bis(chloromethyl)oxane Chemical compound ClCC1(CCl)CCOCC1 UCMPIDSRISWZLR-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- KHVGLJWNCGINJM-UHFFFAOYSA-N [3-methoxy-2-(methoxymethyl)-2-methylpropyl]-dimethylphosphane Chemical compound COCC(C)(COC)CP(C)C KHVGLJWNCGINJM-UHFFFAOYSA-N 0.000 description 2
- AZLCMQNRKHKYTH-UHFFFAOYSA-N [4-(dimethylphosphanylmethyl)oxan-4-yl]methyl-dimethylphosphane Chemical compound CP(C)CC1(CP(C)C)CCOCC1 AZLCMQNRKHKYTH-UHFFFAOYSA-N 0.000 description 2
- NKSPVEFJJKKISK-UHFFFAOYSA-N [4-(hydroxymethyl)oxan-4-yl]methanol Chemical compound OCC1(CO)CCOCC1 NKSPVEFJJKKISK-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- CVDGHGWEHQIJTE-UHFFFAOYSA-N bromo(bromomethoxy)methane Chemical compound BrCOCBr CVDGHGWEHQIJTE-UHFFFAOYSA-N 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- ILUMJWCFQOFDMA-UHFFFAOYSA-N diethyl oxane-4,4-dicarboxylate Chemical compound CCOC(=O)C1(C(=O)OCC)CCOCC1 ILUMJWCFQOFDMA-UHFFFAOYSA-N 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- FCLVHDJMRBTQEI-UHFFFAOYSA-N dimethylphosphanylmethoxymethyl(dimethyl)phosphane Chemical compound CP(C)COCP(C)C FCLVHDJMRBTQEI-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- SGTQXKBRULHMLI-UHFFFAOYSA-N (methyl-$l^{2}-phosphanyl)methane Chemical compound C[P]C SGTQXKBRULHMLI-UHFFFAOYSA-N 0.000 description 1
- XHTYQFMRBQUCPX-UHFFFAOYSA-N 1,1,3,3-tetramethoxypropane Chemical compound COC(OC)CC(OC)OC XHTYQFMRBQUCPX-UHFFFAOYSA-N 0.000 description 1
- JPNFQRZLCFPCIR-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)-3-methoxy-2-(methoxymethyl)propane Chemical compound COCC(CBr)(CBr)COC JPNFQRZLCFPCIR-UHFFFAOYSA-N 0.000 description 1
- TZBZZWBYDXSQTP-UHFFFAOYSA-N 1-dimethylphosphanylethyl(dimethyl)phosphane Chemical compound CP(C)C(C)P(C)C TZBZZWBYDXSQTP-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- VGUUZSMFETVOJZ-UHFFFAOYSA-N 5,5-bis(bromomethyl)-2-phenyl-1,3-dioxane Chemical compound O1CC(CBr)(CBr)COC1C1=CC=CC=C1 VGUUZSMFETVOJZ-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101100135276 Arabidopsis thaliana PLL5 gene Proteins 0.000 description 1
- ZNSMNVMLTJELDZ-UHFFFAOYSA-N Bis(2-chloroethyl)ether Chemical compound ClCCOCCCl ZNSMNVMLTJELDZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 101100356994 Homo sapiens RIPOR2 gene Proteins 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 229910017912 NH2OH Inorganic materials 0.000 description 1
- 229910004878 Na2S2O4 Inorganic materials 0.000 description 1
- 102100032023 Rho family-interacting cell polarization regulator 2 Human genes 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- OEWPQSWDAXMHQG-UHFFFAOYSA-N [Tc+] Chemical compound [Tc+] OEWPQSWDAXMHQG-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005081 alkoxyalkoxyalkyl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-AKLPVKDBSA-N carbane Chemical compound [15CH4] VNWKTOKETHGBQD-AKLPVKDBSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical group FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 108700039708 galantide Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002577 pseudohalo group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 102200012170 rs10084168 Human genes 0.000 description 1
- 102220253208 rs1386720703 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5027—Polyphosphines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/72—Aliphatic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8723438 | 1987-10-06 | ||
GB878723438A GB8723438D0 (en) | 1987-10-06 | 1987-10-06 | Cationic complexes of technetium-99m |
GB8800817 | 1988-10-04 | ||
PCT/GB1988/000817 WO1989003388A1 (en) | 1987-10-06 | 1988-10-04 | Cationic complexes of technetium-99m |
Publications (3)
Publication Number | Publication Date |
---|---|
DK266689A DK266689A (da) | 1989-06-01 |
DK266689D0 DK266689D0 (da) | 1989-06-01 |
DK171487B1 true DK171487B1 (da) | 1996-11-25 |
Family
ID=10624861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK266689A DK171487B1 (da) | 1987-10-06 | 1989-06-01 | Kationiske komplekser med technetium-99m, komplekserne til anvendelse som hjerteafbildende midler og ligander, der er anvendelige i sådanne komplekser |
Country Status (12)
Country | Link |
---|---|
US (1) | US4916214A (ko) |
EP (1) | EP0311352B1 (ko) |
JP (1) | JPH0737472B2 (ko) |
KR (1) | KR970011165B1 (ko) |
AT (1) | ATE63559T1 (ko) |
CA (1) | CA1336438C (ko) |
DE (1) | DE3862843D1 (ko) |
DK (1) | DK171487B1 (ko) |
ES (1) | ES2037234T3 (ko) |
GB (1) | GB8723438D0 (ko) |
IL (1) | IL87944A (ko) |
WO (1) | WO1989003388A1 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8808414D0 (en) * | 1988-04-11 | 1988-05-11 | Amersham Int Plc | Ligands & cationic complexes thereof with technetium-99m |
GB8902362D0 (en) * | 1989-02-03 | 1989-03-22 | Amersham Int Plc | Cationic complexes of technetium-99m |
US4917879A (en) * | 1989-05-19 | 1990-04-17 | University Of Cincinnati | 99MTC(III) myocardial imaging agents that are effective in humans |
US6001979A (en) | 1989-08-29 | 1999-12-14 | Nycomed Amersham Plc | Cores for technetium radiopharmaceuticals |
DD291327A5 (de) * | 1989-12-29 | 1991-06-27 | �������@����@�K@��@��k�� | Myokardgaengige technetium-komplexverbindungen und verfahren zu deren herstellung |
GB2242189A (en) * | 1990-03-23 | 1991-09-25 | Shell Int Research | Bidentate ligands and their precursors |
US5541289A (en) * | 1994-03-30 | 1996-07-30 | Washington University | Phosphine containing amino acids and peptides and methods of preparing and using same |
US5834456A (en) * | 1996-02-23 | 1998-11-10 | The Dow Chemical Company | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents |
IT1286879B1 (it) * | 1996-11-21 | 1998-07-17 | Consiglio Nazionale Ricerche | Leganti 1,3-difosfinopropanici e complessi da essi formati con metalli di transizione,loro preparazione e uso |
DE69721820T2 (de) * | 1996-12-18 | 2004-02-26 | Nihon Medi-Physics Co. Ltd., Nishinomiya | Nitrid-heterokomplexe von radioaktiven übergangsmetallen |
ES2359973T3 (es) * | 1998-03-19 | 2011-05-30 | MERCK SHARP & DOHME CORP. | Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas. |
US6794553B2 (en) | 2001-11-09 | 2004-09-21 | Shell Oil Company | Process for the telomerization of a conjugated diene, catalyst and bidentate ligand useful therein |
EP2899195A1 (en) | 2014-01-28 | 2015-07-29 | ROTOP Pharmaka AG | Stabilized form of Tetrofosmin and its use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2005790A1 (en) * | 1968-04-08 | 1969-12-19 | Toa Gosei Chemical Indus | But-1-ene-2,3,4-tricarboxylic ester is prepared by reacting acrylic ester with maleic or fumaric ester in presence of phosphine-type catalyst. New cpds. a |
US4489054A (en) * | 1980-04-18 | 1984-12-18 | Research Corporation | Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging |
US4387087A (en) * | 1980-04-18 | 1983-06-07 | Research Corporation | Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging |
US4451450A (en) * | 1981-10-15 | 1984-05-29 | New England Nuclear Corporation | Cationic compounds useful for making radiodiagnostic agents |
US4374821A (en) * | 1982-06-28 | 1983-02-22 | E. R. Squibb & Sons, Inc. | Myocardial imaging agent and method |
US4481184A (en) * | 1983-02-14 | 1984-11-06 | E. R. Squibb & Sons, Inc. | Cationic technetium (I) complexes |
US4526776A (en) * | 1983-04-15 | 1985-07-02 | E. I. Du Pont De Nemours & Company | Cationic cyanato and thiocyanato complexes useful as radiodiagnostic agents |
US4795626A (en) * | 1985-05-10 | 1989-01-03 | University Of Cincinnati | 99m Tc.sup.(III) myocardial imaging agents which are non-reducable in vivo |
US4765971A (en) * | 1985-05-31 | 1988-08-23 | Mallinckrodt, Inc. | Technetium (Tc-99m)-arene complexes useful in myocardial imaging |
GB8531296D0 (en) * | 1985-12-19 | 1986-01-29 | Amersham Int Plc | Cationic complexes of technetium |
-
1987
- 1987-10-06 GB GB878723438A patent/GB8723438D0/en active Pending
-
1988
- 1988-10-04 AT AT88309235T patent/ATE63559T1/de not_active IP Right Cessation
- 1988-10-04 EP EP88309235A patent/EP0311352B1/en not_active Expired - Lifetime
- 1988-10-04 WO PCT/GB1988/000817 patent/WO1989003388A1/en unknown
- 1988-10-04 ES ES198888309235T patent/ES2037234T3/es not_active Expired - Lifetime
- 1988-10-04 DE DE8888309235T patent/DE3862843D1/de not_active Expired - Lifetime
- 1988-10-04 KR KR1019890701012A patent/KR970011165B1/ko not_active IP Right Cessation
- 1988-10-05 CA CA000579334A patent/CA1336438C/en not_active Expired - Lifetime
- 1988-10-06 US US07/254,082 patent/US4916214A/en not_active Expired - Lifetime
- 1988-10-06 JP JP63252841A patent/JPH0737472B2/ja not_active Expired - Lifetime
- 1988-10-06 IL IL8794488A patent/IL87944A/en active Protection Beyond IP Right Term
-
1989
- 1989-06-01 DK DK266689A patent/DK171487B1/da active
Also Published As
Publication number | Publication date |
---|---|
KR890701601A (ko) | 1989-12-21 |
ATE63559T1 (de) | 1991-06-15 |
GB8723438D0 (en) | 1987-11-11 |
IL87944A (en) | 1994-07-31 |
IL87944A0 (en) | 1989-03-31 |
KR970011165B1 (ko) | 1997-07-08 |
WO1989003388A1 (en) | 1989-04-20 |
EP0311352A1 (en) | 1989-04-12 |
JPH0737472B2 (ja) | 1995-04-26 |
DE3862843D1 (de) | 1991-06-20 |
DK266689A (da) | 1989-06-01 |
DK266689D0 (da) | 1989-06-01 |
EP0311352B1 (en) | 1991-05-15 |
JPH01128990A (ja) | 1989-05-22 |
CA1336438C (en) | 1995-07-25 |
US4916214A (en) | 1990-04-10 |
ES2037234T3 (es) | 1993-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK171487B1 (da) | Kationiske komplekser med technetium-99m, komplekserne til anvendelse som hjerteafbildende midler og ligander, der er anvendelige i sådanne komplekser | |
US4419339A (en) | Formulation and method of making cationic lipophilic complexes | |
US5188816A (en) | Using polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS | |
US5059412A (en) | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors | |
DK171416B1 (da) | Ligander, og kationiske komplekser deraf med technetium-99m | |
US5064633A (en) | Macrocyclic aminophosphonic acid complexes, their formulations and use | |
WO1993011138A1 (en) | Amine derivatives containing a phosphonic, phosphonous or phosphinic acid moiety | |
EP0386873B1 (en) | Cationic complexes of technetium 99m, and ligands therefor | |
NL8303481A (nl) | Werkwijze voor het radio-afbeelden van het myocardium van zoogdieren onder gebruikmaking van radiogemerkte lipofiele kationen. | |
CA2636499C (en) | Intermediate compound of technetium nitride complex for radiodiagnostic imaging | |
DE4025788C2 (de) | Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung sowie deren Verwendung in Diagnostik und Therapie | |
US6054115A (en) | Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same | |
US3790582A (en) | Certain pyridylphosphates,thiophosphates,phosphonates and thiophosphonates | |
ES2213115T3 (es) | Productos radiofarmaceuticos adecuados para la marcacion selectiva de linfocitos, y su preparacion. | |
Jones et al. | The preparation and reactions of dialkyl-(o-dialkylphosphinophenyl)-arsines | |
ES2547647T3 (es) | Complejos de tricarbonilo con quelantes tridentados para la obtención de imágenes del miocardio | |
JP3619265B2 (ja) | アスコルビン酸−イノシトール結合体またはその塩、ならびにその製造方法 | |
Irino | The Reaction of Elemental Sulfur with Alkyl Alkylphosphinates | |
Abramov et al. | Reaction of dialkylphosphinic acids with aldehydes and ketones. | |
Sprague | CUPROUS-BROMIDE CATALYZED REACTIONS OF ((DIETHOXYPHOSPHINYL) DIFLUOROMETHYL) ZINC-BROMIDE (PHOSPHONATE, FLUORINATED) | |
JPH0797363A (ja) | 新規なキレート形成性化合物とその用途 | |
Sood | Donor interaction studies in phosphites, phosphates and oxyphosphoranes: Models for activated states of phosphoryl transfer enzymes | |
SOWELL SR | Evaluation of 99mTc-Labeled Iminodiacetic Acid Derivatives of Substituted 2-Aminopyrroles as Hepatobiliary Imaging Agents in Rats I1 | |
Sachanandani | Synthesis of organophosphorous hydrazides and structurally related compounds |